Summaries

AdobeStock_340703775

PHE/DH/DWP guideline

PHE management of patient/staff exposure to COVID-19

2020-11-06T09:43:00+00:00By

This summary provides guidance on the management of staff and patients in health and social care settings according to exposures, symptoms, and test results.

Nurse writing notes_AS resized

NHS guideline

NHS England COVID-19 guidance for community pharmacy

2020-10-30T08:30:00+00:00By NHS England and NHS Improvement

This standard operating proedure summary sets out general principles for the delivery of services during the COVID-19 pandemic, and requires local interpretation

AdobeStock_331083828

NICE guideline

COVID-19 rapid guideline: managing COVID-19 symptoms in the community

2020-10-22T00:00:00+01:00By

The purpose of this guideline is to provide recommendations for managing COVID‑19 symptoms for patients in the community, including at the end of life. It also includes recommendations about managing medicines for these patients, and protecting staff from infection

AdobeStock_335029203

PHE/DH/DWP guideline

PHE COVID-19 infection prevention and control guidance

2020-09-08T17:10:00+01:00By

Summary of the latest UK guidance on infection prevention and control measures for COVID-19.

AdobeStock_292279272

NICE guideline

COVID-19 rapid guideline: gastrointestinal and liver conditions treated with drugs affecting the immune response

2020-08-25T13:28:00+01:00By

The purpose of this guideline is to maximise the safety of children and adults who have gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic.

Pills + magnifying glass

NHS guideline

NHS guidance on NSAIDs in COVID-19

2020-06-26T12:57:00+01:00By NHS England

This summary sets out the clinical policy for the acute use of non-steroidal anti-inflammatory drugs (NSAIDs) in people with or at risk of COVID-19.

AdobeStock_162937550

NICE guideline

COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders

2020-05-22T00:44:00+01:00By

The purpose of this guideline is to maximise the safety of children and adults with rheumatological autoimmune, inflammatory and metabolic bone disorders during the COVID-19 pandemic, while protecting staff from infection. It also enables services to make the best use of NHS resources

AdobeStock_287082164

NICE guideline

COVID-19 rapid guideline: dermatological conditions treated with drugs affecting the immune response

2020-05-01T14:42:00+01:00By

The purpose of this Guidelines summary is to maximise the safety of children and adults who have dermatological conditions treated with drugs affecting the immune response during the COVID-19 pandemic. 

Pneumonia

NICE guideline

COVID-19 rapid guideline: pneumonia in adults

2020-04-27T00:11:00+01:00By

The purpose of this guideline is to ensure the best treatment for adults with suspected or confirmed pneumonia in the community during the COVID-19 pandemic.

AdobeStock_332747243

NICE guideline

COVID-19 rapid guideline: community-based care of patients with chronic obstructive pulmonary disease (COPD)

2020-04-17T17:02:00+01:00By

The purpose of this summary is to maximise the safety of patients with chronic obstructive pulmonary disease (COPD) during the COVID-19 pandemic, while protecting staff from infection. It will also enable services to make the best use of NHS resources. For more detailed information, please refer to the full guideline.

AdobeStock_289304487

NICE guideline

COVID-19 rapid guideline: severe asthma

2020-04-17T13:39:00+01:00By

The purpose of this guideline is to maximise the safety of adults and children with severe asthma during the COVID-19 pandemic, while protecting staff from infection. It will also enable services to make the best use of NHS resources.